I. Musé

发表

Predictive value of 99mTc sestamibi scintigraphy in the evaluation of doxorubicin based chemotherapy response in patients with advanced breast cancer

O. Alonso, L. Delgado, M. Núñez, 2002 .

Hereditary breast cancer associated with a germline BRCA2 mutation in identical female twins with similar disease expression.

B. Bressac-de Paillerets, J. Bombled, G. Gualco, 2002, Cancer genetics and cytogenetics.

BRCA1 and BRCA2 germline mutations in Uruguayan breast and breast–ovarian cancer families. Identification of novel mutations and unclassified variants

G. Sabini, I. Musé, L. Delgado, 2011, Breast Cancer Research and Treatment.

Molecular detection of cancer cells in bone marrow and peripheral blood of patients with operable breast cancer. Comparison of CK19, MUC1 and CEA using RT-PCR.

E. Osinaga, E. Barrios, F. Simonet, 2000, European journal of cancer.

Detection of rare human breast cancer cells. Comparison of an immunomagnetic separation method with immunocytochemistry and RT-PCR.

E. Osinaga, I. Musé, N. Berois, 1997, Anticancer research.

Acute promyelocytic leukemia after treatment of malignant glioma in a patient with von Recklinghausen's disease: case report and review of the literature.

P. Wiernik, I. Musé, 1996, Leukemia.

Familial uveal melanoma: report on three sibling cases

M. Echenique, L. Delgado, I. Musé, 2001, The British journal of ophthalmology.

Clinical evaluation of a panel of mRNA markers in the detection of disseminated tumor cells in patients with operable breast cancer.

E. Osinaga, E. Barrios, I. Musé, 2005, Oncology reports.

Breast cancer management in middle-resource countries (MRCs): consensus statement from the Breast Health Global Initiative.

C. Yip, F. Cardoso, Ying Zheng, 2011, Breast.

A Phase I Trial of Cisplatin Plus Decitabine, a New DNA-Hypomethylating Agent, in Patients with Advanced Solid Tumors and a Follow-Up Early Phase II Evaluation in Patients with Inoperable Non-Small Cell Lung Cancer

G. Schwartsmann, C. Garbino, G. Sabini, 2000, Investigational New Drugs.

Tumoral expression of BRCA1, Estrogen receptor alpha and ID4 protein in patients with sporadic breast cancer

G. Roldan, I. Musé, L. Delgado, 2006, Cancer biology & therapy.

Breast cancer management in middle-resource countries (MRCs): consensus statement from the Breast Health Global Initiative.

C. Yip, F. Cardoso, Ying Zheng, 2011, Breast.